ENTELOS EXPANDS J&J DRUG DISCOVERY COLLABORATION

A A

Entelos, a company specializing in predictive biosimulation technologies for drug discovery, development, and commercialization, has expanded its research collaboration with Johnson & Johnson Pharmaceutical R&D, to include multiple therapeutic areas over a five-year term. During the first year of this new agreement, Entelos will dedicate several teams of research engineers and life scientists to support specific projects using its PhysioLab platforms on behalf of J&J and its affiliates.

Computer Business Review Online (http://www.cbronline.com/article_news.asp?guid=7AD0FB02-DB37-4C73-A867-A714B2B717C8)